Disruption of laboratory activities during the COVID-19 pandemic: results of an EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey.

COVID-19 Laboratory Medicine SARS-CoV-2 Survey

Journal

EJIFCC
ISSN: 1650-3414
Titre abrégé: EJIFCC
Pays: Italy
ID NLM: 101092742

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 23 10 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: epublish

Résumé

The EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) created a survey that has been distributed to its members for gathering information on the key hazards experienced by European medical laboratories during the COVID-19 pandemic. The survey was distributed to over 12,000 potential contacts (laboratory workers) via an EFLM newsletter, with responses collected between May 8 and June 8, 2023. Two hundred replies were collected and examined from European laboratories. 69.7% and 78.1% of all responders said they were short on non-COVID and COVID reagents, respectively. Exactly half of respondents (50.0%) said that they could not complete all laboratory tests required for a specific period, but this figure climbed to 61.2% for COVID tests. Finally, 72.3% of respondents expressed exhaustion during the pandemic, and 61.2% reported increasing patient hostility. The COVID-19 pandemic had a significant impact on laboratory medicine in Europe. Cultural change, proactive planning, and even re-engineering in some parts of the laboratory industry may thus be necessary to prepare for future challenges.

Sections du résumé

Background UNASSIGNED
The EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) created a survey that has been distributed to its members for gathering information on the key hazards experienced by European medical laboratories during the COVID-19 pandemic.
Methods UNASSIGNED
The survey was distributed to over 12,000 potential contacts (laboratory workers) via an EFLM newsletter, with responses collected between May 8 and June 8, 2023.
Results UNASSIGNED
Two hundred replies were collected and examined from European laboratories. 69.7% and 78.1% of all responders said they were short on non-COVID and COVID reagents, respectively. Exactly half of respondents (50.0%) said that they could not complete all laboratory tests required for a specific period, but this figure climbed to 61.2% for COVID tests. Finally, 72.3% of respondents expressed exhaustion during the pandemic, and 61.2% reported increasing patient hostility.
Conclusions UNASSIGNED
The COVID-19 pandemic had a significant impact on laboratory medicine in Europe. Cultural change, proactive planning, and even re-engineering in some parts of the laboratory industry may thus be necessary to prepare for future challenges.

Identifiants

pubmed: 37868082
pii: ejifcc-34-213
pmc: PMC10588075

Types de publication

Journal Article

Langues

eng

Pagination

213-219

Informations de copyright

Copyright © 2023 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest The authors declare no conflict of interest

Références

Ann Med Surg (Lond). 2020 Jul 18;57:70-75
pubmed: 32704368
Clin Chem Lab Med. 2020 Jul 28;58(8):1171
pubmed: 32069231
Science. 2023 May 12;380(6645):566-567
pubmed: 37167400
Front Psychiatry. 2023 Jan 12;13:1071397
pubmed: 36713915
Arch Pathol Lab Med. 2023 Mar 1;147(3):368-375
pubmed: 35802936
Clin Microbiol Infect. 2023 May;29(5):560-562
pubmed: 36773772
J Nutr Health Aging. 2020;24(9):973-974
pubmed: 33155623
Nat Med. 2022 Jun;28(6):1314-1324
pubmed: 35288697
Ann Transl Med. 2020 Feb;8(3):48
pubmed: 32154288
Lab Med. 2021 Jul 1;52(4):e115-e124
pubmed: 33942859
Ecol Lett. 2023 Apr;26(4):485-489
pubmed: 36849208
Front Psychol. 2022 Sep 21;13:952783
pubmed: 36211838
Ir J Med Sci. 2022 Feb;191(1):65-69
pubmed: 33665780
Clin Chem Lab Med. 2021 Apr 07;:
pubmed: 33826810
BMJ. 2023 May 9;381:1041
pubmed: 37160309
Crit Care Clin. 2019 Oct;35(4):591-607
pubmed: 31445607
Clin Chem Lab Med. 2010 May;48(5):573-5
pubmed: 20450330

Auteurs

Giuseppe Lippi (G)

Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.

Janne Cadamuro (J)

Department of Laboratory Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.

Elisa Danese (E)

Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.

Emmanuel J Favaloro (EJ)

Haematology, NSW Health Pathology, Sydney Centres for Thrombosis and Haemostasis, ICPMR, Westmead Hospital, Sydney, Australia.

Julien Favresse (J)

Services of Clinical Biology, Clinic Saint-Luc, Bouge, Belgium.

Brandon M Henry (BM)

Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.

Snezana Jovicic (S)

Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.

Tomris Ozben (T)

Department of Medical Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

Mario Plebani (M)

University of Padova, Padova, Italy.

Jecko Thachil (J)

Immune Thrombocytopenic Purpura (ITP) Clinic, Haematology Department, Manchester University NHS Foundation Trust - Manchester Royal Infirmary, Manchester, UK.

Classifications MeSH